The TM-2440 is compact & lightweight Ambulatory Blood Pressure Monitors, which incorporate our latest technology gained from over 40 years experience in developing and manufacturing precision measurement equipment.
This ABPM range was validated in accordance with the new ISO810601-2 protocol, and the blood pressure accuracy was proven to be +/-3mmHg.
- 24 hour ambulatory blood pressure monitoring range of devices
- Light weight – from 122 grams (excluding batteries)
- Compact – only 66mm x 24.5mm x 95mm (WxHxD)
- Oscillometric measuring method
- Irregular Heartbeat detection (IHB)
- Automatically adjusts: Proper Cuff Pressure, Exhaust, End of Measurement
- Battery Power – only 2 alkaline or Ni-MH AA batteries
- Multiple measurement intervals – adapts to patient’s and healthcare professional’s exact requirements
- USB cable data output to computer or printer
- Local memory recording for up to 600 sets of data
- 24-hour clock and calendar
- Waterproof and Dustproof to IP22 Standard – designed ‘with the patient in mind’
- Can be integrated into an Electronic Patient Record System (EPR)
- Secure screw thread cuff connection – to avoid accidental disconnection/error readings
- OLED – Ambulatory monitoring display
- 4 cuff options ranging from 15cm to 50cm
- Accuracy: blood pressure +/-3mmHg; pulse +/-5%
- Clinically Validated to ISO810601-2
Unlike some less thoughtfully designed ambulatory devices which are heavy, cumbersome and uncomfortable, and based on traditional desktop/home use type monitors, the new TM-2440 is designed specifically for purpose:
Weight: The weight of an Ambulatory monitor is a big factor when it comes to patient comfort and getting the best results. With the TM-2440 weighing only 122 grams, this makes the new A&D range the lightest in this class.
This helps ensure that your patient will hardly know they are wearing their A&D Ambulatory Monitor.
Compact Design: The size of an Ambulatory Monitor is another important factor when choosing a device that a patient can easily wear comfortably and discreetly for long periods of time.
The TM-2440 is the smallest in class, measuring just 66mm x 24.5mm x 95mm (WxHxD). This again, helps ensure that your patient hardly notices they are wearing their A&D Ambulatory Monitor.
<strong>Soft cloth cuff: Unlike some of the rough plastic cuffs available on some older devices, the TM-2440 benefit from a soft, machine washable cloth, to ensure maximum comfort whilst the patient wears the device over long periods of time.
The cuff range offers Upper Arm fitting from 15cm through to 50cm – ensuring peace of mind and a comfortable, accurate fit.
The TM-2440 is truly ‘designed with the patient in mind.’
Connectivity: The A&D ABPM range offers USB as standard. This allows flexibility and easy data transfer to Electronic Patient Record (EPR) systems.
Secure threaded cuff connection: Unlike some older ABPMs that have a push in connector, the TM-2440 benefit from a secure thread-locking connection. This helps to ensure the cuff doesn’t become detached whilst the patient is wearing the device during their everyday life, and that their readings are not lost or inaccurate.
The importance of ABPM in managing hypertension has been acknowledged in hypertension guidelines and a number of authoritative bodies have now issued guidelines on the use of ABPM. A taskforce of participants at the 1999 Consensus Conference on ABP monitoring, sponsored by the International Society of Hypertension, suggested that:
‘ABPM should be performed only with properly validated devices as an accessory to conventional measurement of BP [blood pressure]. ABPM requires considerable investment in equipment and training and its use for screening purposes cannot be recommended.
ABPM is most useful for identifying patients with white-coat hypertension (WCH), also known as isolated clinic hypertension.
ABPM or equivalent methods for tracing the white-coat effect should become part of the routine diagnostic and therapeutic procedures applied to treated and untreated patients with elevated clinic blood pressures. Results of long-term outcome trials should better establish the advantage of further integrating ABPM as an accessory to conventional sphygmomanometry into the routine care of hypertensive patients and should provide more definite information on the long-term cost-effectiveness.’
